HomeRUBICON • NSE
add
Rubicon Research Ltd
Nakaraang pagsara
₹898.90
Sakop ng araw
₹891.05 - ₹938.70
Sakop ng taon
₹570.75 - ₹938.70
Market cap
153.85B INR
Average na Volume
209.24K
P/E ratio
71.47
Dividend yield
-
Primary exchange
NSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 4.76B | 51.73% |
Gastos sa pagpapatakbo | 2.22B | 43.88% |
Net na kita | 727.97M | 91.20% |
Net profit margin | 15.31 | 26.01% |
Kita sa bawat share | 4.41 | — |
EBITDA | 1.12B | 70.15% |
Aktuwal na % ng binabayarang buwis | 19.64% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.51B | — |
Kabuuang asset | — | — |
Kabuuang sagutin | — | — |
Kabuuang equity | 6.47B | — |
Natitirang share | 163.22M | — |
Presyo para makapag-book | 21.42 | — |
Return on assets | — | — |
Return on capital | 19.87% | — |
Cash Flow
Net change in cash
| (INR) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 727.97M | 91.20% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Rubicon Research is an Indian pharmaceutical company located in Mumbai.
The company has its corporate headquarters and R&D center in Thane, India, an R&D center in Concord, Canada, manufacturing plants located in Ambernath, Satara and Pithampur, India, and a regulatory office in East Windsor, US. Wikipedia
Itinatag
1999
Website
Mga Empleyado
1,141
